Regeneron Pharmaceuticals Inc 2025 SR
The report outlines Regeneron's sustainability progress and achievements in 2025, marking the completion of its 2025 responsibility goals and introducing its new 2030 goals. Key highlights include a 46% reduction in combined Scope 1 and 2 greenhouse gas emissions intensity, sourcing 52% of electricity from certified renewable sources, and diverting 99% of waste from landfills. The company also expanded its clinical pipeline to nearly 50 candidates, secured 11 new product indication approvals, and provided STEM experiences to over 4 million students since 2020.
Company: Regeneron Pharmaceuticals Inc
Sector: Manufacturing
Country: United States
Year: 2025
Type: SR
Pages: 80
Back to company
Regeneron Pharmaceuticals Inc
Responsibility Report
The report outlines Regeneron's sustainability progress and achievements in 2025, marking the completion of its 2025 responsibility goals and introducing its new 2030 goals. Key highlights include a 46% reduction in combined Scope 1 and 2 greenhouse gas emissions intensity, sourcing 52% of electricity from certified renewable sources, and diverting 99% of waste from landfills. The company also expanded its clinical pipeline to nearly 50 candidates, secured 11 new product indication approvals, and provided STEM experiences to over 4 million students since 2020.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2025 - Dec 31, 2025
Fiscal Year
2025
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Renewable Energy
Water Consumption
Total Waste
Women in Management
Workplace Fatalities
Employees